Beyond Checkpoint Inhibitors: Ernexa Therapeutics on ERNA-101's Novel Cell Therapy Approach

Immunologically "cold" tumors remain one of the greatest challenges in oncology, limiting the effectiveness of checkpoint inhibitors in cancers such as pla...

August 06, 2026 | Thursday | Interview
CEO Norman Schwartz Reaffirms Bio-Rad’s 2026 Outlook Despite Life Science Headwinds

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced financial results...

August 06, 2026 | Thursday | Company results
IQVIA and Medera Partner to Advance Cardiac Gene Therapy Development

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...

August 06, 2026 | Thursday | News
GE HealthCare Launches Invenia ABUS Prime and ABUS StreamVue for Dense Breast Screening

Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles...

August 05, 2026 | Wednesday | News
Pathos AI and AstraZeneca Partner to Advance AZD4241 for ER+/HER2- Breast Cancer

Pathos assumes responsibility for early clinical development of AZD4241, utilizing its AI-driven Foundry platform to drive patient stratification and t...

August 05, 2026 | Wednesday | News
From Documentation to Detection: How AI Is Changing the APP Role

Artificial intelligence is transforming the role of advanced practice providers (APPs) by streamlining documentation, simplifying clinical workfl...

August 03, 2026 | Monday | Interaction
MIMEDX to Acquire Sanara MedTech in $350 Million Deal to Expand Regenerative Medicine Portfolio

Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX’s Strategi...

July 31, 2026 | Friday | News
Basilea Secures Additional USD 30 Million BARDA Funding for Phase 3 Antifungal Program

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

July 29, 2026 | Wednesday | News
Huonslab Secured Patent for HyDIFFUZE™-Based Subcutaneous ADC Formulation Technology

Demonstrates competitiveness of hyaluronidase-based ADC SC conversion platform Confirms stability of high-concentration ADC SC formulations and improv...

July 29, 2026 | Wednesday | News
Marc Casper Leads Thermo Fisher to Double-Digit Q2 Growth, Strengthening 2026 Outlook

  “We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strategy, our team’s excellen...

July 28, 2026 | Tuesday | Company results
Sanofi Discontinues Development of Amlitelimab for Atopic Dermatitis

Sanofi announced the discontinuation of clinical development of amlitelimab, an OX40-ligand monoclonal antibody, in moderate-to-severe atopic dermatitis ...

July 28, 2026 | Tuesday | News
Arcus Biosciences and AVEO Partner to Evaluate Casdatifan Plus Tivozanib in Kidney Cancer Study

  This agreement supports a new randomized cohort within the ARC-20 study evaluating investigational casdatifan plus tivozanib versus tivozanib a...

July 24, 2026 | Friday | News
BioTalent Canada and BAM Partner to Expand AI Training for Manitoba’s Bio-Economy

  BioTalent Canada and Bioscience Association Manitoba (BAM) today announced a collaboration to expand access to “AI Fundamentals for the Bio-e...

July 24, 2026 | Friday | News
Dassault Systèmes to Acquire ArisGlobal to Build AI-Native Intelligence Platform for Life Sciences

  ArisGlobal brings a mission-critical, AI-native platform spanning regulatory, safety, quality and medical affairs that serves as a single sourc...

July 24, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close